宇能制药 (873992.OC)

+ 收藏

利润表(宇能制药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2025年中报2024年年报2024年中报2023年年报2023年中报2023年一季报
上市前/上市后 上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 会员可见会员可见会员可见会员可见111,020,442.5662,446,725.70
 营业收入(元) 会员可见会员可见会员可见会员可见111,020,442.5662,446,725.70
二、营业总成本(元) 会员可见会员可见会员可见会员可见85,255,739.4451,767,178.13
 营业成本(元) 会员可见会员可见会员可见会员可见73,478,905.1046,094,279.62
 研发费用(元) 会员可见会员可见会员可见会员可见5,491,815.202,826,903.46
 营业税金及附加(元) 会员可见会员可见会员可见会员可见546,813.35301,654.81
 销售费用(元) 会员可见会员可见会员可见会员可见732,663.57407,338.61
 管理费用(元) 会员可见会员可见会员可见会员可见4,164,405.891,676,810.95
 财务费用(元) 会员可见会员可见会员可见会员可见841,136.33460,190.68
  其中:利息费用(元) 会员可见会员可见会员可见会员可见954,647.78509,903.84
三、其他经营收益
 资产减值损失(元) -会员可见-会员可见5,777.74-
 信用减值损失(元) 会员可见会员可见会员可见会员可见-870,515.15-1,226,938.50
 其他收益(元) 会员可见会员可见会员可见会员可见1,836,938.222,006,773.85
四、营业利润(元) 会员可见会员可见会员可见会员可见26,736,903.9311,459,382.92
 加:营业外收入(元) 会员可见会员可见会员可见会员可见2,517,674.001,888.37
 减:营业外支出(元) 会员可见会员可见会员可见会员可见14,678.9024,406.90
五、利润总额(元) 会员可见会员可见会员可见会员可见29,239,899.0311,436,864.39
 减:所得税费用(元) 会员可见会员可见会员可见会员可见3,774,942.921,410,077.36
六、净利润(元) 会员可见会员可见会员可见会员可见25,464,956.1110,026,787.03
(一)按经营持续性分类
  持续经营净利润(元) 会员可见会员可见会员可见会员可见25,464,956.1110,026,787.03
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 会员可见会员可见会员可见会员可见25,464,956.1110,026,787.03
 扣除非经常性损益后的净利润(元) 会员可见会员可见会员可见会员可见21,776,029.22-
七、每股收益
 一、基本每股收益(元) 会员可见会员可见会员可见会员可见1.040.41
 二、稀释每股收益(元) 会员可见会员可见会员可见会员可见1.040.41
九、综合收益总额(元) 会员可见会员可见会员可见会员可见25,464,956.1110,026,787.03
 归属于母公司所有者的综合收益总额(元) 会员可见会员可见会员可见会员可见25,464,956.1110,026,787.03
公告日期 2025-08-272025-04-162024-08-292024-03-292023-08-282023-07-12
审计意见(境内) -标准无保留意见-标准无保留意见--
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院